Literature DB >> 6771279

The structures of the cross-reactive types 19 (19F) and 57 (19A) pneumococcal capsular polysaccharides.

C J Lee, B A Fraser.   

Abstract

The structures for two cross-reactive capsular polysaccharides isolated from Streptococci pneumoniae types 19 and 57 are proposed based on the analytical data obtained from methylation, enzymatic degradation, and periodate oxidation experiments performed on both intact polysaccharides and oligosaccharides isolated from hydrofluoric acid hydrolysates. Both polysaccharides exhibit an identical structure of 4)-beta-2-acetamido-2-deoxymannose-(1 leads to 4)-alpha-D-glucose-(1 leads to 2)-alpha-L-rhamnose-1-phosphate. This trisaccharide is considered the only repeating unit in the type 19 polysaccharide. The type 57 polysaccharide contains this same repeating unit and side chains composed of a beta-D-2-acetamido-2-deoxyglucose-(1 leads to 3)-beta-D-galactose-1-phosphate side chain attached to C-2 of the glucose and an alpha-L-fucose-1-phosphate attached to C-3 of the rhamnose.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771279

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Comparative genetics of capsular polysaccharide biosynthesis in Streptococcus pneumoniae types belonging to serogroup 19.

Authors:  J K Morona; R Morona; J C Paton
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

Review 2.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

3.  Precipitating cross-reactions among pneumococcal types.

Authors:  M Heidelberger
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

4.  Pneumococcal serotype 19F conjugate vaccine induces cross-protective immunity to serotype 19A in a murine pneumococcal pneumonia model.

Authors:  Håvard Jakobsen; Viktor D Sigurdsson; Sigurveig Sigurdardottir; Dominique Schulz; Ingileif Jonsdottir
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

5.  Polysaccharide Capsule Composition of Pneumococcal Serotype 19A Subtypes Is Unaltered among Subtypes and Independent of the Nutritional Environment.

Authors:  Silvio D Brugger; Lukas J Troxler; Susanne Rüfenacht; Pascal M Frey; Brigitte Morand; Rudolf Geyer; Kathrin Mühlemann; Stefan Höck; Wolfgang Thormann; Julien Furrer; Stephan Christen; Markus Hilty
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

6.  Molecular and genetic characterization of the capsule biosynthesis locus of Streptococcus pneumoniae type 19B.

Authors:  J K Morona; R Morona; J C Paton
Journal:  J Bacteriol       Date:  1997-08       Impact factor: 3.490

7.  Effect of culture conditions on the structure of Streptococcus pneumoniae type 19A(57) capsular polysaccharide.

Authors:  C J Lee; B A Fraser; R A Boykins; J P Li
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

8.  Cross-immunogenicity of pneumococcal group 9 capsular polysaccharides in adult volunteers.

Authors:  S C Szu; C J Lee; J C Parke; G Schiffman; J Henrichsen; R Austrian; S C Rastogi; J B Robbins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

9.  Antibody responses in adult volunteers to pneumococcal polysaccharide types 19F and 19A administered singly and in combination.

Authors:  R L Penn; E B Lewin; R G Douglas; G Schiffman; C J Lee; J B Robbins
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

10.  Distribution of mannosamine and mannosaminuronic acid among cell walls of Bacillus species.

Authors:  T Yoneyama; Y Koike; H Arakawa; K Yokoyama; Y Sasaki; T Kawamura; Y Araki; E Ito; S Takao
Journal:  J Bacteriol       Date:  1982-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.